Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-BMEZ for Chemotherapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where PEGFILGRASTIM-BMEZ was used for Chemotherapy.

Most Reported Side Effects for PEGFILGRASTIM-BMEZ

Side Effect Reports % Deaths Hosp.
Death 121 30.3% 121 2
Drug ineffective 35 8.8% 4 15
Neutropenia 34 8.5% 4 25
Pyrexia 23 5.8% 0 12
Febrile neutropenia 17 4.3% 1 13
Malaise 17 4.3% 0 2
Neoplasm malignant 16 4.0% 8 2
Stenotrophomonas infection 16 4.0% 0 16
Off label use 15 3.8% 0 11
Leukopenia 13 3.3% 0 4
Hospitalisation 12 3.0% 2 11
Illness 10 2.5% 2 1
Drug reaction with eosinophilia and systemic symptoms 9 2.3% 0 8
Thrombocytopenia 9 2.3% 0 5
Febrile bone marrow aplasia 8 2.0% 0 5

Other Indications for PEGFILGRASTIM-BMEZ

Product used for unknown indication (206) Neutropenia (30) Prophylaxis (17) Blood disorder prophylaxis (10) Agranulocytosis (7) Colony stimulating factor therapy (6) Breast cancer (5) Febrile neutropenia (5) Hodgkin's disease (5)

Other Drugs Used for Chemotherapy

CYCLOPHOSPHAMIDE (3,372) DOCETAXEL (2,134) CARBOPLATIN (1,902) DOXORUBICIN (1,756) VINCRISTINE (1,743) PACLITAXEL (1,425) OXALIPLATIN (1,423) METHOTREXATE (1,380) CYTARABINE (1,355) ETOPOSIDE (1,246)

Related Pages

PEGFILGRASTIM-BMEZ Full Profile All Chemotherapy Drugs PEGFILGRASTIM-BMEZ Demographics PEGFILGRASTIM-BMEZ Timeline